Reilly Joseph H.

Avg. Two Year Performance

No purchase track record

64% Avg. Sale Return

28% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(5%)	28%	28%	40%	64%
Sale Success Rate	3 of 7	4 of 7	5 of 7	5 of 7	4 of 7

Minerva Neurosciences, Inc.

Drugs » Biotechnology

SVP & Chief Operating Officer:

Holdings: 31.75K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--